BIOTECHNOLOGY RESEARCH FOUNDATION

Belkins
Biotechnology research foundation is available to undertake consultancy projects or contribute in an advisory role in the following areas , Bio remediation, Environmental Impact Assessment , Designing Monitoring and Verification mechanisms for Carbon Emissions , Soil Testing, Hydroponics, Tissue Culture , DNA , GMO Monitoring, Building Waste Treatment Technologies and Agricultural Biotechnology

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

IMMUNOSCAPE INTENSELY ENGAGED IN IMMUNOLOGY BREAKTHROUGHS FOR COVID-19 RAISED $11M IN A GLOBAL EQUITY FINANCING

ImmunoScape | August 13, 2020

news image

ImmunoScape (www.ImmunoScape.com), a biotech firm enabling unprecedented insights into the human immune system, today announced that it has raised USD $11 million (SGD $14.8 million) in a global equity financing round. US-based venture firm Anzu Partners led the round, joined by University of Tokyo Edge Capital (UTEC) in Japan, and NPR Holdings in Indonesia.ImmunoScape's immune profiling platform, which provides deep insights into the T-cells of the human immune system, is already inte...

Read More

RESEARCH

BIO-TECHNE AND CARTERRA INITIATE A CLINICAL RESEARCH COLLABORATION FOR COVID-19 VARIANT ANALYSIS

Bio-Techne Corporation | September 08, 2021

news image

Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, today announced a clinical research collaboration studying COVID-19 variants. New variants, such as Delta, can be more easily transmitted and more likely to evade the immune response of vaccinated or previously infected people. To assess immune responses to ...

Read More

MEDTECH

PRECISION COATING ANNOUNCES MERGER WITH N2 BIOMEDICAL TO EXPAND MEDICAL COATINGS PLATFORM

N2 Biomedical | September 20, 2021

news image

Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company. N2 Biomedical, an Ampersand Capital Partners portfolio company, provides nano-engineered surface treatment and coating services to the medical device industry with its low-temperature Ion Implantation Surface Treatments and Ion Beam Assisted Deposition (IBAD) technologies. ...

Read More

ALX RAISES $105M FOR MIDPHASE TRIALS OF CD47 CANCER DRUG

FierceBiotech | February 12, 2020

news image

ALX Oncology has raised $105 million. The series C round will support phase 2 trials of CD47 myeloid checkpoint inhibitor ALX148 in combination with other anti-cancer therapies. Multiple drug developers have gone after CD47 since evidence of its role in the interactions between cancer cells and the immune system became clear. The evidence suggested tumors evade immune attacks by upregulating CD47, leading researchers to posit that blocking the signal will expose cancer cells to a full-force offe...

Read More

ImmunoScape | August 13, 2020

news image

IMMUNOSCAPE INTENSELY ENGAGED IN IMMUNOLOGY BREAKTHROUGHS FOR COVID-19 RAISED $11M IN A GLOBAL EQUITY FINANCING

ImmunoScape (www.ImmunoScape.com), a biotech firm enabling unprecedented insights into the human immune system, today announced that it has raised USD $11 million (SGD $14.8 million) in a global equity financing round. US-based venture firm Anzu Partners led the round, joined by University of Tokyo Edge Capital (UTEC) in Japan, and NPR Holdings in Indonesia.ImmunoScape's immune profiling platform, which provides deep insights into the T-cells of the human immune system, is already inte...

Read More

RESEARCH

Bio-Techne Corporation | September 08, 2021

news image

BIO-TECHNE AND CARTERRA INITIATE A CLINICAL RESEARCH COLLABORATION FOR COVID-19 VARIANT ANALYSIS

Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, today announced a clinical research collaboration studying COVID-19 variants. New variants, such as Delta, can be more easily transmitted and more likely to evade the immune response of vaccinated or previously infected people. To assess immune responses to ...

Read More

MEDTECH

N2 Biomedical | September 20, 2021

news image

PRECISION COATING ANNOUNCES MERGER WITH N2 BIOMEDICAL TO EXPAND MEDICAL COATINGS PLATFORM

Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company. N2 Biomedical, an Ampersand Capital Partners portfolio company, provides nano-engineered surface treatment and coating services to the medical device industry with its low-temperature Ion Implantation Surface Treatments and Ion Beam Assisted Deposition (IBAD) technologies. ...

Read More

FierceBiotech | February 12, 2020

news image

ALX RAISES $105M FOR MIDPHASE TRIALS OF CD47 CANCER DRUG

ALX Oncology has raised $105 million. The series C round will support phase 2 trials of CD47 myeloid checkpoint inhibitor ALX148 in combination with other anti-cancer therapies. Multiple drug developers have gone after CD47 since evidence of its role in the interactions between cancer cells and the immune system became clear. The evidence suggested tumors evade immune attacks by upregulating CD47, leading researchers to posit that blocking the signal will expose cancer cells to a full-force offe...

Read More